Literature DB >> 23222816

Targeted expression of ornithine decarboxylase antizyme prevents upper aerodigestive tract carcinogenesis in p53-deficient mice.

David J Feith1, Anthony E Pegg, Louise Y Y Fong.   

Abstract

Upper aerodigestive tract (UADT) cancers of the oral cavity and esophagus are a significant global health burden, and there is an urgent need to develop relevant animal models to identify chemopreventive and therapeutic strategies to combat these diseases. Antizyme (AZ) is a multifunctional negative regulator of cellular polyamine levels, and here, we evaluate the susceptibility of keratin 5 (K5)-AZ transgenic mice to tumor models that combine chemical carcinogenesis with dietary and genetic risk factors known to influence human susceptibility to UADT cancer and promote UADT carcinogenesis in mice. First, p53(+/-) and K5-AZ/p53(+/-) (AZ/p53(+/-)) mice were placed on a zinc-deficient (ZD) or zinc-sufficient (ZS) diet and chronically exposed to 4-nitroquinoline 1-oxide. Tongue tumor incidence, multiplicity and size were substantially reduced in both ZD and ZS AZ/p53(+/-) mice compared with p53(+/-). AZ expression also reduced progression to carcinoma in situ or invasive carcinoma and decreased expression of the squamous cell carcinoma biomarkers K14, cyclooxygenase-2 and metallothionein. Next, AZ-expressing p53(+/-) and p53 null mice were placed on the ZD diet and treated with a single dose of N-nitrosomethylbenzylamine. Regardless of p53 status, forestomach (FST) tumor incidence, multiplicity and size were greatly reduced with AZ expression, which was also associated with a significant decrease in FST epithelial thickness along with reduced proliferation marker K6 and increased differentiation marker loricrin. These studies demonstrate the powerful tumor suppressive effects of targeted AZ expression in two distinct and unique mouse models and validate the polyamine metabolic pathway as a target for chemoprevention of UADT cancers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23222816      PMCID: PMC3581602          DOI: 10.1093/carcin/bgs377

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  54 in total

1.  Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion-sensitive and promotion-resistant genetic backgrounds.

Authors:  David J Feith; Lisa M Shantz; Paula L Shoop; Kerry A Keefer; Chethana Prakashagowda; Anthony E Pegg
Journal:  Mol Carcinog       Date:  2007-06       Impact factor: 4.784

2.  Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis.

Authors:  D J Feith; L M Shantz; A E Pegg
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

Review 3.  Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer.

Authors:  Rachelle R Olsen; Bruce R Zetter
Journal:  Mol Cancer Res       Date:  2011-08-17       Impact factor: 5.852

4.  Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.

Authors:  Louise Y Y Fong; Liang Zhang; Yubao Jiang; John L Farber
Journal:  J Natl Cancer Inst       Date:  2005-01-05       Impact factor: 13.506

Review 5.  Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program.

Authors:  V E Steele; R C Moon; R A Lubet; C J Grubbs; B S Reddy; M Wargovich; D L McCormick; M A Pereira; J A Crowell; D Bagheri
Journal:  J Cell Biochem Suppl       Date:  1994

Review 6.  Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor.

Authors:  Chaim Kahana
Journal:  Essays Biochem       Date:  2009-11-04       Impact factor: 8.000

Review 7.  Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases.

Authors:  Robert A Casero; Laurence J Marton
Journal:  Nat Rev Drug Discov       Date:  2007-05       Impact factor: 84.694

8.  Chemoprevention of oral carcinogenesis by DL-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor: dose-dependent reduction in 4-nitroquinoline 1-oxide-induced tongue neoplasms in rats.

Authors:  T Tanaka; T Kojima; A Hara; H Sawada; H Mori
Journal:  Cancer Res       Date:  1993-02-15       Impact factor: 12.701

9.  Prognostic impact of metallothionein on oral squamous cell carcinoma.

Authors:  Sérgio V Cardoso; Hugo M Barbosa; Ignez M Candellori; Adriano M Loyola; Maria Cássia F Aguiar
Journal:  Virchows Arch       Date:  2002-02-05       Impact factor: 4.064

Review 10.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

View more
  4 in total

Review 1.  Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use.

Authors:  John F Atkins; Gary Loughran; Pramod R Bhatt; Andrew E Firth; Pavel V Baranov
Journal:  Nucleic Acids Res       Date:  2016-07-19       Impact factor: 16.971

Review 2.  Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.

Authors:  Yao Liu; Hao Chen; Zheng Sun; Xiaoxin Chen
Journal:  Cancer Lett       Date:  2015-03-09       Impact factor: 8.679

3.  Role of ornithine decarboxylase/polyamine pathway in focal cerebral ischemia-reperfusion injury and its mechanism in rats.

Authors:  Li Ding; Xiao-Hong Ba
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 4.  Polyamine metabolism and cancer: treatments, challenges and opportunities.

Authors:  Robert A Casero; Tracy Murray Stewart; Anthony E Pegg
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.